question · intermediate · partly written
Does in vitro screening kill projects that would have worked?
No opened source measures false-negative kills by in vitro assays.
Observation
His claim that in vitro is "a quick way to kill a project" is an experience claim; the sources opened measure other things. 1
Amit's hypothesis
What is known
What is not
How often in vitro assays reject candidates that would have worked in humans was not found; Kola and Landis 2004 was not opened. 2
Reported, not yet replicated
What would settle it
Prospective follow-up of candidates dropped at an in vitro gate, compared with candidates that passed. 2
Our inference
Still open here
- Does the "ten drugs" count in the atlas's Lin 2019 note appear in the paper? It is not in the abstract.
Not yet written: Hypotheses, What is missing, Who works on it.
Linked from
Sources
- Amit's dictation of 2026-11-17: what the atlas must contain. Kept in the atlas repository; not published.
- Moshkov et al.. Predicting compound activity from phenotypic profiles and chemical structures (Moshkov et al. 2023), Europe PMC listing. Europe PMC listing (2023). paper; opened 2026-11-17 all records citing this
- Ben-David U, Siranosian B, Ha G, et al.. Genetic and transcriptional evolution alters cancer cell line drug response. Nature (2018). paper; opened 2026-11-17 all records citing this
- Lin, Ann, Giuliano, Christopher J., Palladino, Ann, et al.. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials. Science Translational Medicine (2019). paper; opened 2026-11-17 all records citing this
History of this record (1)
This record has been changed 1 time, on the dates below. The note kept against each change is written for the people who maintain the atlas, in their own shorthand, so it is not shown here; it is in the record itself.
- Kind
- amit
- Register
- open-question
- Status
- partly written
- Last updated
- 2026-11-17
- Record
- content/questions/does-in-vitro-screening-kill-projects-that-would-have-worked.json